Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 3
Submit an article Journal homepage
2,040
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro

Hai XuDepartment of Cardiology, The First Afliated Hospital of Nanjing Medical University, Huaian City, Jiangsu Province, ChinaView further author information
,
Xiwen ZhangDepartment of Cardiology, The First Afliated Hospital of Nanjing Medical University, Huaian City, Jiangsu Province, ChinaView further author information
,
Yafei ShiDepartment of Cardiology, The First Afliated Hospital of Nanjing Medical University, Huaian City, Jiangsu Province, ChinaView further author information
,
Kun YuDepartment of Cardiology, The First Afliated Hospital of Nanjing Medical University, Huaian City, Jiangsu Province, ChinaView further author information
&
Yicheng JiangDepartment of Cardiology, The First Afliated Hospital of Nanjing Medical University, Huaian City, Jiangsu Province, ChinaCorrespondence[email protected]
View further author information
Pages 5653-5662 | Received 03 Nov 2021, Accepted 29 Jan 2022, Published online: 09 Mar 2022

References

  • Heusch G, Libby P, Gersh B, et al. Cardiovascular remodelling in coronary artery disease and heart failure[J]. Lancet. 2014;383(9932):1933–1943.
  • Jin L, Zhang Y, Jiang Y, et al. Circular RNA Rbms1 inhibited the development of myocardial ischemia reperfusion injury by regulating miR-92a/BCL2L11 signaling pathway. Bioengineered. 2022;13(2):3082–3092.
  • Huangfu F, Tang L, Wang H, et al. MiR-145-5p promotes myocardial cell apoptosis in rats with myocardial infarction through PI3K/Akt signaling pathway[J]. Eur Rev Med Pharmacol Sci. 2020;24(24):12904–12911.
  • Zhou M, Zou Y, Xue Y, et al. Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice[J]. Eur Rev Med Pharmacol Sci. 2018;22(17):5647–5651.
  • Xin P, Xu X, Deng C, et al. The role of JAK/STAT signaling pathway and its inhibitors in diseases[J]. Int Immunopharmacol. 2020;80:106210.
  • Boengler K, Hilfiker-Kleiner D, Drexler H, et al. The myocardial JAK/STAT pathway: from protection to failure[J]. Pharmacol Ther. 2008;120(2):172–185.
  • Chen X, Wang Y, Xiao Z, et al. Effect of propofol on myocardial ischemia/reperfusion injury in rats through JAK/STAT signaling pathway[J]. Eur Rev Med Pharmacol Sci. 2019;23(14):6330–6338.
  • Fan C, Chen Q, Ren J, et al. Notoginsenoside R1 Suppresses Inflammatory Signaling and Rescues Renal Ischemia-Reperfusion Injury in Experimental Rats[J]. Med Sci Monit. 2020;26:e920442.
  • Zhai Y, Meng X, Luo Y, et al. Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation[J]. Oncotarget. 2018;9(10):9344–9363.
  • Zhu L, Gong X, Gong J, et al. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-kappaB pathway in HUVECs[J]. Braz J Med Biol Res. 2020;53(6):e9346.
  • Yu Y, Sun G, Luo Y, et al. Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways[J]. Sci Rep. 2016;6(1):21730.
  • Li Z, Li H, Zhao C, et al. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer’s Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Abeta Accumulation[J]. CNS Neurol Disord Drug Targets. 2015;14(3):360–369.
  • Chen Y, Zeng L, Lu Y, et al. Treatment effect of a flavonoid prescription on duck virus hepatitis by its hepatoprotective and antioxidative ability[J]. Pharm Biol. 2017;55(1):198–205.
  • Lu M, Xie K, Lu X, et al. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling[J]. Invest New Drugs. 2021;39(2):416–425.
  • Sun B, Xiao J, Sun XB, et al. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling[J]. Br J Pharmacol. 2013;168(7):1758–1770.
  • Curley D, Lavin Plaza B, M SA, et al. Molecular imaging of cardiac remodelling after myocardial infarction[J]. Basic Res Cardiol. 2018;113(2):1–18.
  • Boarescu P, Chirilă I, E BA, et al. Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction[J]. Oxid Med Cell Longev. 2019;2019:7847113–7847142.
  • Ling L, Gu S, Cheng Y. Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction[J]. Mol Med Rep. 2017;15(3):1188–1194.
  • Zhou P, Xie W, Meng X, et al. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy[J]. Cells (Basel, Switzerland). 2019;8(3):213.
  • Zhang J, Zheng Q, and Lu H, et al. Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88[J]. Int J Immunopathol Pharmacol. 2019 ;33:2058738419857550.
  • Luo C, Sun Z, Li Z, et al. Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats[J]. Med Sci Monit. 2019;25:1177–1186.
  • P BS, A TP, S LD, et al. Role of the JAK-STAT pathway in myocardial injury[J]. Trends Mol Med. 2007;13(2):82–89.
  • Du S, Zeng F, Sun H, et al. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Bioengineered. 2022;13(2):2498–2512.
  • Hattori R, Maulik N, Otani H, et al. Role of STAT3 in Ischemic Preconditioning[J]. J Mol Cell Cardiol. 2001;33(11):1929–1936.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.